BECTON, DICKINSON AND COMPANY

The Life Science Instrumentation market is projected to grow from $75.9B in 2023 to $104B by 2030, driven by technological innovations, automation, and the shift towards precision medicine. Key trends include high-throughput screening, synthetic biology, and CRISPR gene editing. Major players include Agilent Technologies, Becton Dickinson, and Bio-Rad Laboratories.

The global market for molecular diagnostics in infectious diseases is rapidly growing, driven by technological advancements and global trends like climate change and globalization. This report offers insights into market strategies, trends, and forecasts from 2023 to 2027, focusing on applications such as transplant and respiratory diagnostics. It highlights the importance of rapid diagnostic methodologies and the role of diagnostics in combating infectious diseases, providing stakeholders with essential data for informed decision-making in this evolving sector.

The In Vitro Diagnostic Market is projected to grow from USD 102.18 billion in 2024 to USD 131.66 billion by 2029, at a CAGR of 5.20%. Growth is driven by chronic and infectious diseases prevalence, advanced diagnostic technologies, and personalized medicine acceptance. North America leads due to its healthcare industry and chronic disease burden. Market players focus on product launches and acquisitions to expand their portfolios and meet regulatory standards.